Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Chronic Kidney DiseaseDiabetes
Interventions
DRUG

Febuxostat

80 mg/day of febuxostat for 24 weeks

DRUG

Placebo

1 placebo tablet per day for 24 weeks

Trial Locations (1)

84112

University of Utah, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

University of Utah

OTHER

NCT01350388 - Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease | Biotech Hunter | Biotech Hunter